1) systemic sclerosis
系统性硬化病
1.
Systemic sclerosis(SSc)is a generalized autoimmune disease,of yet unknown origin.
系统性硬化病(SSc)是一种累及多系统的疾病,属于自身免疫性疾病,病因和发病机制尚不清楚,迄今尚无有效的方法能够阻止SSc疾病进展、逆转皮肤及内脏器官纤维化。
2) progressive systemic sclerosis(PSS)
进行性系统性硬化病
3) Systemic sclerosis
系统性硬化
1.
Clinical Analysis of 32 Cases of Systemic Sclerosis;
系统性硬化32例临床分析
4) systemic scleroderma
系统性硬皮病
1.
Effect of Wubi Capsules on immune function in patients with systemic scleroderma;
五痹胶囊对系统性硬皮病患者免疫功能的影响
2.
The Association Analysis of HLA-DRB1 Allele and Systemic Scleroderma in Guangxi;
HLA-DRB1与广西地区系统性硬皮病的相关性研究
3.
Objective To study therapeutic efficacy of steaming therapy of Chinese drugs on treating systemic scleroderma(SSc) compared with oral decoction for Chinese drugs.
目的了解中药熏蒸疗法对系统性硬皮病(SSc)病人的疗效是否优于口服中药。
5) systemic sclerosis
系统性硬皮病
1.
Effect of acitretin on the proliferation and TGF-β_1 secretion of fibroblasts in systemic sclerosis;
阿维A酸对系统性硬皮病患者成纤维细胞增殖及分泌TGF-β_1的影响
2.
Clinical Significance of Determining Anti-endothelial Cell Antibodies in Systemic Sclerosis;
系统性硬皮病患者血清抗内皮细胞抗体水平检测及临床意义
3.
The detection and analysis of antinuclear antibodies in Systemic Sclerosis;
系统性硬皮病抗核抗体谱的检测分析
6) systemic sclerosis
系统性硬化症
1.
Glucocorticoid combined with mycophenolate mofetil for treatment of 5 patients with systemic sclerosis accompanied by pulmonary hypertension;
糖皮质激素加霉酚酸酯治疗系统性硬化症合并肺动脉高压5例
2.
Clinical evaluation of EDTA in treatment of systemic sclerosis;
依地酸钙钠治疗系统性硬化症86例
3.
ObjectiveTo investigate the clinical efficacy of Shenzhe Zhuyun mixture (SZM) in treating esophageal lesion in patients with systemic sclerosis.
目的探讨参赭助运合剂对系统性硬化症(systemic sclerosis,SSc)患者食管病变的临床疗效。
补充资料：骨硬化病
骨硬化病
osteopectrosis，Ａlbers-Ｓchonberg disease
1904年由Albers-Schonberg首先描述。骨的密度和厚度均增加，骨小梁基本消失，但骨的形态不变。患者全身性骨硬化，骨干有纵纹，椎体有典型的“运动衫”横条。头颅增厚导致脑神经受压出现麻痹。骨髓造血功能受影响。骨脆弱易发生病理性骨折。严重患者易出血或感染而早期死亡。目前无特效疗法。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条